Dedicated to Maximizing the Therapeutic Index of Your ADC
The 11th World ADC San Diego will return in 2021 as the industry-leading comprehensive forum for the antibody drug conjugate field.
With the recent approval in 2020 and 8 ADCs now on the market, the sky is the limit for ADCs as they have well and truly proven their potential. World ADC aims to learn from these approvals and hear from the leading drug developers pushing to get the next ADC on the market.
Bringing together ADC experts from pharma, biotech and academia, this unique platform will provide you with unrivaled networking opportunities with senior level drug developers as well as ground-breaking science and solution-led case studies. Delving into the pioneering developments from early discovery through to manufacturing, this is 4 days your team cannot afford to miss!
About World ADC Series
The World ADC team ploughs its collective energy into sourcing the insights you need. We investigate the most challenging problems facing the industry; source the leading experts who have game-changing solutions; and distill this into accessible formats of information exchange – for you. From globally leading conferences, to webinars and industry reports, whatever the information you need, World ADC can offer you the insights you need to accelerate your ADC programs.
The value World ADC provides you is the power of insight and connections. Not artificial, and not short-lived. We nurture the right environments in which people can communicate problems and solutions; share novel data and forge networks across the industry that will make each of your endeavors more informed and more robust.
We share a common belief with the industry – that the potential of antibody drug conjugates is enormous. In the war against cancer, ADCs can be a game-changer and we know that the right insights and connections can sharpen the weapons that are in your arsenal.
Join us at the heart of the ADC community to improve your programs and be part of the mission to develop better antibody drug conjugate drugs.